n-succinimidyl 3-(2-pyridyldithio)propionate has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alauddin, MM; Epstein, AL; Glasky, MS; Khawli, LA | 1 |
| Fishelson, Z; Reiter, Y | 1 |
| Canevari, S; Colnaghi, MI; Leoni, F; Mezzanzanica, D; Orlandi, R; Ripamonti, M | 1 |
3 other study(ies) available for n-succinimidyl 3-(2-pyridyldithio)propionate and Neoplasms
| Article | Year |
|---|---|
Improved tumor localization and radioimaging with chemically modified monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Cross-Linking Reagents; Humans; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Neoplasms; Radioimmunodetection; Succinimides; Tissue Distribution; Tumor Cells, Cultured | 1996 |
Killing of human tumor cells by antibody C3b conjugates and human complement.
Topics: Antibodies, Monoclonal; Cell Death; Complement C3b; Complement System Proteins; Cross-Linking Reagents; Cytotoxicity Tests, Immunologic; Electrophoresis, Polyacrylamide Gel; Glutaral; Humans; Immunoelectrophoresis; Neoplasms; Succinimides; Tumor Cells, Cultured | 1989 |
Change in binding reactivity of an anti-tumor monoclonal antibody after the introduction of 2-pyridyl disulphide groups.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antigen-Antibody Reactions; Antigens, Neoplasm; Cell Line; Immunoglobulin M; Mice; Neoplasms; Ricin; Succinimides | 1986 |